| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |